The drug responsible for the distinctive hunched-over posture you’ve likely seen in news footage or on social media is xylazine, a veterinary tranquilizer that has rapidly infiltrated the illegal drug supply. Street names include “tranq” and “tranq dope,” and the frozen, bent-at-the-waist stance it produces is widely called the “tranq lean.” The posture happens because xylazine is a powerful sedative that was never meant for human use. It suppresses brain activity and relaxes muscles so profoundly that people lose the ability to hold themselves upright while remaining partially conscious.
Why Xylazine Causes the Tranq Lean
Xylazine works by activating a specific type of receptor in the nervous system that dials down signals between the brain and body. In veterinary medicine, this is useful for sedating horses and cattle during procedures. In humans, the same mechanism slows breathing, drops blood pressure, lowers heart rate, and produces extreme muscle relaxation. The result is a person who is sedated but not fully unconscious, standing or swaying in a bent-over position because their muscles can no longer support normal posture. Unlike opioids, xylazine produces no euphoria on its own. Users describe the effects as overwhelmingly sedative.
What makes this posture so common on the street today is that most people consuming xylazine don’t know they’re taking it. It’s mixed into fentanyl, heroin, and sometimes cocaine, either to stretch the supply or intensify the sedation. The combination of an opioid high with xylazine’s deep tranquilizing effect is what pins people in that characteristic fold. They aren’t choosing to stand that way. Their nervous system is being suppressed on two fronts at once.
How Widespread Xylazine Has Become
Xylazine’s presence in the drug supply has grown fast. In 2023, 30% of fentanyl powder seized by the DEA contained xylazine, up from 25% the year before. Fentanyl pills were less commonly laced, with about 6% testing positive. The contamination is not limited to any single region, though it first became visible in Philadelphia and other East Coast cities before spreading nationally.
The death toll reflects this spread. Overdose deaths involving both fentanyl and xylazine rose from 99 in 2018 to over 6,000 in 2023, a nearly 6,000% increase in five years. That surge is not because xylazine alone is typically fatal. It’s because the combination of a powerful sedative with a powerful opioid compounds the risk of fatal respiratory failure.
Why Xylazine Makes Overdoses Harder to Reverse
Naloxone (the overdose-reversal medication carried by first responders and available over the counter) works by blocking opioid receptors. It can reverse the effects of fentanyl or heroin. But xylazine is not an opioid. It acts on a completely different part of the nervous system, which means naloxone does nothing to counteract its effects. If someone has taken fentanyl laced with xylazine, naloxone can still help with the opioid component and is always worth administering. But the person may remain dangerously sedated, with slowed breathing and a weak heartbeat, even after naloxone is given. There is currently no widely available reversal agent for xylazine in humans.
Skin Wounds and Other Physical Effects
Beyond the hunched posture, xylazine is associated with severe skin wounds that develop near injection sites and sometimes on parts of the body far from where the drug was injected. These wounds can become deep, necrotic ulcers that resist healing and, in some cases, lead to amputation. The exact mechanism behind the wounds is not fully understood, but reduced blood flow from xylazine’s effects on the cardiovascular system likely plays a role. The wounds were one of the first clinical signs that tipped off public health officials to xylazine’s growing presence in the drug supply.
Withdrawal From Xylazine
People who use xylazine regularly, often unknowingly through contaminated fentanyl, report that withdrawal is more painful than opioid withdrawal alone. Standard opioid withdrawal already involves intense discomfort: muscle aches, nausea, anxiety, insomnia. Xylazine adds its own layer of symptoms on top of that, and the sudden appearance or worsening of skin wounds during withdrawal is common.
Treatment options remain limited. Because xylazine belongs to a class of drugs that includes clonidine (a blood pressure medication), clonidine has been used with some success to ease xylazine withdrawal symptoms. But there is no established, FDA-approved protocol for xylazine detox the way there is for opioids. Users have reported frustration with a lack of clinician awareness. Many healthcare providers are still unfamiliar with xylazine exposure and its specific withdrawal profile, creating a gap between what patients need and what treatment facilities currently offer.
Other Drugs That Affect Posture
Xylazine is the primary drug behind the hunched-over images circulating widely today, but it’s worth noting that heavy opioid use on its own can produce a similar “nodding” posture, where someone drifts in and out of consciousness while standing. The difference is that opioid nodding tends to involve more movement, with the person’s head and body bobbing as they cycle between wakefulness and sedation. The tranq lean from xylazine is more static, with people frozen in a bent position for extended periods, sometimes appearing almost locked in place. Synthetic cathinones (sometimes called bath salts) and high doses of certain antipsychotic medications can also cause unusual postures, but neither produces the specific hunched-over presentation that xylazine does.